3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Leukemia, Myeloid, Acute
4
Hematologic Neoplasms
4
Melanoma
3
Lymphoma
3
Sarcoma
2
Recurrence
2
Osteosarcoma
2
Neuroblastoma
2
Neoplasms
2
Myelodysplastic Syndromes
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Lymphoid
2
Leukemia, B-Cell
2
Leukemia
2
Wilms Tumor
1
Teratoma
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Preleukemia
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Neurofibrosarcoma
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms by Histologic Type
1
Meningeal Neoplasms
1
Lymphoproliferative Disorders
1
Lymphoma, Non-Hodgkin
1
Interventions
Bevacizumab
39
atezolizumab
26
durvalumab
24
Nivolumab
21
lenvatinib
20
tremelimumab
16
Specimen Handling
16
Magnetic Resonance Spectroscopy
13
sintilimab
11
pembrolizumab
11
Ipilimumab
10
tislelizumab
7
X-Rays
7
Sorafenib
7
Immunoglobulin G
7
regorafenib
6
Disulfides
6
Cyclophosphamide
6
cabozantinib
5
Radiotherapy
5
Radiosurgery
5
Blood Specimen Collection
5
Radiation
4
Oxaliplatin
4
Immunotherapy
4
Fluorouracil
4
Ethiodized Oil
4
Biopsy
4
fludarabine
3
donafenib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Mesna
×
90 days
×
Clear all
No trials found.